264 related articles for article (PubMed ID: 23830564)
21. Impact of Drusen Volume on Quantitative Fundus Autofluorescence in Early and Intermediate Age-Related Macular Degeneration.
Reiter GS; Told R; Schlanitz FG; Bogunovic H; Baumann L; Sacu S; Schmidt-Erfurth U; Pollreisz A
Invest Ophthalmol Vis Sci; 2019 May; 60(6):1937-1942. PubMed ID: 31050721
[TBL] [Abstract][Full Text] [Related]
22. Deep Learning Automated Detection of Reticular Pseudodrusen from Fundus Autofluorescence Images or Color Fundus Photographs in AREDS2.
Keenan TDL; Chen Q; Peng Y; Domalpally A; Agrón E; Hwang CK; Thavikulwat AT; Lee DH; Li D; Wong WT; Lu Z; Chew EY
Ophthalmology; 2020 Dec; 127(12):1674-1687. PubMed ID: 32447042
[TBL] [Abstract][Full Text] [Related]
23. Incidence and progression of reticular drusen in age-related macular degeneration: findings from an older Australian cohort.
Joachim N; Mitchell P; Rochtchina E; Tan AG; Wang JJ
Ophthalmology; 2014 Apr; 121(4):917-25. PubMed ID: 24332537
[TBL] [Abstract][Full Text] [Related]
24. Spectral and lifetime resolution of fundus autofluorescence in advanced age-related macular degeneration revealing different signal sources.
Schultz R; Hasan S; Curcio CA; Smith RT; Meller D; Hammer M
Acta Ophthalmol; 2022 May; 100(3):e841-e846. PubMed ID: 34258885
[TBL] [Abstract][Full Text] [Related]
25. Characterization of Drusen and Hyperreflective Foci as Biomarkers for Disease Progression in Age-Related Macular Degeneration Using Artificial Intelligence in Optical Coherence Tomography.
Waldstein SM; Vogl WD; Bogunovic H; Sadeghipour A; Riedl S; Schmidt-Erfurth U
JAMA Ophthalmol; 2020 Jul; 138(7):740-747. PubMed ID: 32379287
[TBL] [Abstract][Full Text] [Related]
26. Peripheral Changes Associated With Delayed Dark Adaptation in Age-related Macular Degeneration.
Laíns I; Park DH; Mukai R; Silverman R; Oellers P; Mach S; Kim IK; Vavvas DG; Miller JW; Miller JB; Husain D
Am J Ophthalmol; 2018 Jun; 190():113-124. PubMed ID: 29621510
[TBL] [Abstract][Full Text] [Related]
27. Identification of Drusen Characteristics in Age-Related Macular Degeneration by Polarization-Sensitive Optical Coherence Tomography.
Schlanitz FG; Sacu S; Baumann B; Bolz M; Platzer M; Pircher M; Hitzenberger CK; Schmidt-Erfurth U
Am J Ophthalmol; 2015 Aug; 160(2):335-344.e1. PubMed ID: 25982973
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of Peripheral Retinal Changes on Ultra-Widefield Fundus Autofluorescence Images of Patients with Age-Related Macular Degeneration.
Küçükiba K; Erol N; Bilgin M
Turk J Ophthalmol; 2020 Mar; 50(1):6-14. PubMed ID: 32166942
[TBL] [Abstract][Full Text] [Related]
29. Predictors for the progression of geographic atrophy in patients with age-related macular degeneration: fundus autofluorescence study with modified fundus camera.
Jeong YJ; Hong IH; Chung JK; Kim KL; Kim HK; Park SP
Eye (Lond); 2014 Feb; 28(2):209-18. PubMed ID: 24458203
[TBL] [Abstract][Full Text] [Related]
30. Clinically detectable drusen domains in fibulin-5-associated age-related macular degeneration (AMD) : Drusen subdomains in fibulin-5 AMD.
Kucukevcilioglu M; Patel CB; Stone EM; Russell SR
Int Ophthalmol; 2016 Aug; 36(4):569-75. PubMed ID: 26694911
[TBL] [Abstract][Full Text] [Related]
31. Fundus autofluorescence in patients with age-related macular degeneration and high risk of visual loss.
Lois N; Owens SL; Coco R; Hopkins J; Fitzke FW; Bird AC
Am J Ophthalmol; 2002 Mar; 133(3):341-9. PubMed ID: 11860971
[TBL] [Abstract][Full Text] [Related]
32. Functional aspects of drusen regression in age-related macular degeneration.
Sallo FB; Rechtman E; Peto T; Stanescu-Segall D; Vogt G; Bird AC; Fitzke FW
Br J Ophthalmol; 2009 Oct; 93(10):1345-50. PubMed ID: 19535356
[TBL] [Abstract][Full Text] [Related]
33. Spectral-domain optical coherence tomography characteristics of intermediate age-related macular degeneration.
Leuschen JN; Schuman SG; Winter KP; McCall MN; Wong WT; Chew EY; Hwang T; Srivastava S; Sarin N; Clemons T; Harrington M; Toth CA
Ophthalmology; 2013 Jan; 120(1):140-50. PubMed ID: 22968145
[TBL] [Abstract][Full Text] [Related]
34. Automatic drusen quantification and risk assessment of age-related macular degeneration on color fundus images.
van Grinsven MJ; Lechanteur YT; van de Ven JP; van Ginneken B; Hoyng CB; Theelen T; Sánchez CI
Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):3019-27. PubMed ID: 23572106
[TBL] [Abstract][Full Text] [Related]
35. Reduction of retinal sensitivity in eyes with reticular pseudodrusen.
Ooto S; Ellabban AA; Ueda-Arakawa N; Oishi A; Tamura H; Yamashiro K; Tsujikawa A; Yoshimura N
Am J Ophthalmol; 2013 Dec; 156(6):1184-1191.e2. PubMed ID: 23972310
[TBL] [Abstract][Full Text] [Related]
36. Multispectral Pattern Recognition Reveals a Diversity of Clinical Signs in Intermediate Age-Related Macular Degeneration.
Ly A; Nivison-Smith L; Assaad N; Kalloniatis M
Invest Ophthalmol Vis Sci; 2018 Apr; 59(5):1790-1799. PubMed ID: 29610844
[TBL] [Abstract][Full Text] [Related]
37. Drusen Volume as a Predictor of Disease Progression in Patients With Late Age-Related Macular Degeneration in the Fellow Eye.
Abdelfattah NS; Zhang H; Boyer DS; Rosenfeld PJ; Feuer WJ; Gregori G; Sadda SR
Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1839-46. PubMed ID: 27082298
[TBL] [Abstract][Full Text] [Related]
38. Computer-assisted, interactive fundus image processing for macular drusen quantitation.
Shin DS; Javornik NB; Berger JW
Ophthalmology; 1999 Jun; 106(6):1119-25. PubMed ID: 10366080
[TBL] [Abstract][Full Text] [Related]
39. Computational quantification of complex fundus phenotypes in age-related macular degeneration and Stargardt disease.
Quellec G; Russell SR; Scheetz TE; Stone EM; Abràmoff MD
Invest Ophthalmol Vis Sci; 2011 May; 52(6):2976-81. PubMed ID: 21310908
[TBL] [Abstract][Full Text] [Related]
40. Fluorescence Lifetimes of Drusen in Age-Related Macular Degeneration.
Dysli C; Fink R; Wolf S; Zinkernagel MS
Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4856-4862. PubMed ID: 28973332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
